Find News

Filter articles

Applied Filters

Showing 1 to 10 of 227 results

BGI counter sues Illumina for patent infringement

China, US04-10-2019Saman Javed

A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.

USPTO grants new CRISPR-Cas9 patent to University of California

US03-10-2019Rory O'Neill

The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio.

Taiwanese firm accuses Pacific Biosciences of infringing sequencing tech

Taiwan, US30-09-2019Sarah Morgan

Taiwan-based Personal Genomics Taiwan has taken gene-sequencing rival Pacific Biosciences to court in the US, over alleged patent infringement.

Oxford Nanopore signs CRISPR licence

UK20-09-2019Sarah Morgan

UK-based Oxford Nanopore has obtained a licence to CRISPR-Cas9 IP for nanopore sequencing, a third-generation approach used in the sequencing of biopolymers.

University of Columbia and Illumina locked in DNA patent battle

US12-09-2019Rory O'Neill

The University of Columbia has hit Illumina with a patent infringement suit relating to next-generation DNA sequencing, just days after the pharmaceutical company had one of the university’s patents invalidated at the US Patent and Trial Appeal Board.

UK govt invests in ‘world's largest’ genetics research project


The world's ”largest genetics project” to tackle deadly diseases was launched yesterday, September 11, supported by funding from the UK government, charities and four pharmaceutical companies.

Gene-editing alliance releases bioethical framework

International03-09-2019Sarah Morgan

An alliance of companies that use gene-editing technologies has released a bioethical framework, as controversy over gene-editing continues.

WHO launches genome editing registry

International03-09-2019Sarah Morgan

The World Health Organization has launched a global registry to track research on human genome editing.

Eli Lilly unit accuses Alzheimer's institute of ‘malicious’ patent prosecution

US14-08-2019Sarah Morgan

Avid Radiopharmaceuticals, a subsidiary of Eli Lilly, has taken the Alzheimer's Institute of America to court over its “malicious” prosecution of a patent infringement case.

Broad hits out at UC Berkeley in latest CRISPR battle


Tensions appear to be running high in the dispute between the Broad Institute of MIT and Harvard and the University of California, Berkeley (UC Berkeley) over which first invented the CRISPR gene-editing technology.

Showing 1 to 10 of 227 results